1-2 of 2
Michael C. Sabel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, Jörg Felsberg, Joachim P. Steinbach, Antje Wick, Oliver Schnell, Peter Hau, Ulrich Herrlinger, Michael C. Sabel, Hans-Georg Wirsching, Ralf Ketter, Oliver Bähr, Michael Platten, Jörg C. Tonn, Uwe Schlegel, Christine Marosi, Roland Goldbrunner, Roger Stupp, Krisztian Homicsko, Josef Pichler, Guido Nikkhah, Jürgen Meixensberger, Peter Vajkoczy, Spyros Kollias, Johannes Hüsing, Guido Reifenberger, Wolfgang Wick
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (9): 2057–2064.
https://doi.org/10.1158/1078-0432.CCR-14-2737
Published: 30 April 2015
View article titled, <em>MGMT</em> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Open the PDF for <em>MGMT</em> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial in another window
Includes: Supplementary data
Journal Articles

Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients

Jörg Felsberg, Marion Rapp, Simon Loeser, Rolf Fimmers, Walter Stummer, Matthias Goeppert, Hans-Jacob Steiger, Britta Friedensdorf, Guido Reifenberger, Michael C. Sabel
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (21): 6683–6693.
https://doi.org/10.1158/1078-0432.CCR-08-2801
Published: 02 November 2009
View article titled, Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
Open the PDF for Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients in another window
Includes: Supplementary data